Argentina

Argentina’s medicines regulator, ANMAT, is updating the national pharmacopeia with new guidelines on advanced therapies.

New rules in Argentina mean that good manufacturing practices certificates for foreign drug manufacturing plants issued by certain regulatory authorities could lead to quicker GMP certification evaluations.

Argentina has implemented a nation-wide traceability system for medicines for the first time.

Companies operating in Argentina may get their medicines to the market more quickly thanks to new updates to the medicines authorization system.

Lupin has added two ADHD drugs to its Canadian portfolio, while also signing multiple branded deals in other global markets.

Number of regulators formally agreeing to work toward creating Latin American regulator is growing.

The number of regulators formally agreeing to work towards creating a Latin American regulator is growing.

Medicines regulators from Mexico, Colombia and Cuba have pledged to create a new agency for medicines and medical devices of Latin America and the Caribbean.

Laboratorio Elea has struck a deal with Nichi-Iko Pharmaceutical to market the Japanese firm’s infliximab biosimilar in Argentina.

The Russian Direct Investment Fund says it has 20 technology transfer and production agreements in place in 13 countries across the world.

While the US and EU regulators seem less than keen on the data package offered to date on COVID-19 Vaccine AstraZeneca, Latin American countries are moving quickly to follow the UK in backing the cost-effective and more-easily deliverable option.

The latest round-up from the Pink Sheet of developments relating to COVID-19.